Conflicts of Interest

And so, another working week will soon draw to a close. You knew this would happen, yes? As you know, this is our treasured signal to daydream about weekend plans. Candidly, we have a rather modest agenda. We hope to catch up on paperwork and reading, indulge the shortest of our short people and take a nap or three. And what about you? This is a fine time of year to enjoy the great outdoors, unless a hurricane is stopping by. In that event, you could tidy up around the castle, reach out to someone special or simply plan the rest of your life. Well, whatever you do, have a grand time. But be safe. See you soon…

Hillary Clinton wants stricter federal regulation of prescription painkillers; Harvard Medical School is reevaluating conflict-of-interest rules amid complaints by some professors the restrictions slow the process of turning discoveries into research tools and treatments; The FDA approved the first therapy combining two cutting-edge cancer agents to treat advanced melanoma; the US Federal Trade Commission argued in a court filing that drug makers that make minor tweaks to their medicines in order to blunt competition from cheaper generics may be violating antitrust laws; and Italy’s Guido Rasi will resume leadership of the European Medicines Agency.